$72.6 Million is the total value of Virtus ETF Advisers LLC's 153 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OMER | OMEROS CORP | $679,000 | -2.4% | 44,237 | 0.0% | 0.94% | -51.0% | |
| KERX | KERYX BIOPHARMACEUTICALS INC | $637,000 | -7.5% | 136,472 | 0.0% | 0.88% | -53.6% | |
| ARNA | ARENA PHARMACEUTICALS INC | $637,000 | +3.7% | 323,107 | 0.0% | 0.88% | -47.9% | |
| VNDA | VANDA PHARMACEUTICALS INC | $560,000 | -10.3% | 67,021 | 0.0% | 0.77% | -54.9% | |
| AMGN | AMGEN INC | $546,000 | -7.8% | 3,644 | 0.0% | 0.75% | -53.7% | |
| GILD | GILEAD SCIENCES INC | $534,000 | -9.2% | 5,810 | 0.0% | 0.74% | -54.4% | |
| NKTR | NEKTAR THERAPEUTICS | $526,000 | -18.4% | 38,260 | 0.0% | 0.72% | -59.0% | |
| SGEN | SEATTLE GENETICS INC | $510,000 | -21.9% | 14,541 | 0.0% | 0.70% | -60.8% | |
| CELG | CELGENE CORP | $489,000 | -16.4% | 4,884 | 0.0% | 0.67% | -58.0% | |
| MDCO | MEDICINES CO | $487,000 | -14.9% | 15,331 | 0.0% | 0.67% | -57.3% | |
| PGNX | PROGENICS PHARMACEUTICALS IN | $453,000 | -28.8% | 103,807 | 0.0% | 0.62% | -64.3% | |
| ALXN | ALEXION PHARMACEUTICALS INC | $441,000 | -27.0% | 3,167 | 0.0% | 0.61% | -63.3% | |
| IONS | IONIS PHARMACEUTICALS INC | $423,000 | -34.6% | 10,447 | 0.0% | 0.58% | -67.2% | |
| RTRX | RETROPHIN INC | $391,000 | -29.2% | 28,634 | 0.0% | 0.54% | -64.4% | |
| ANAC | ANACOR PHARMACEUTICALS INC | $275,000 | -52.7% | 5,147 | 0.0% | 0.38% | -76.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| REGENERON PHARMACEUTICALS | 31 | Q3 2023 | 1.8% |
| INCYTE CORP | 31 | Q3 2023 | 2.1% |
| ENANTA PHARMACEUTICALS INC | 31 | Q3 2023 | 2.2% |
| EXELIXIS INC | 31 | Q3 2023 | 1.8% |
| VANDA PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| IRONWOOD PHARMACEUTICALS INC | 31 | Q3 2023 | 2.0% |
| LIGAND PHARMACEUTICALS INC | 31 | Q3 2023 | 1.5% |
| GILEAD SCIENCES INC | 31 | Q3 2023 | 1.6% |
| HALOZYME THERAPEUTICS INC | 31 | Q3 2023 | 1.7% |
View Virtus ETF Advisers LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-15 |
| 13F-HR | 2023-11-07 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Virtus ETF Advisers LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.